Medulloblastoma is divided into four biologically different subsets of tumors defined as Wnt, Shh, Group 3 and Group 4 that have distinct genetic profiles, pathway signatures, and clinicopathological properties [3, 4]. The gene discussed is SHH; the disease is medulloblastoma.